SCHEMBL3373248

SCHEMBL3373248

CCS(=O)(=O)Oc1cccc(C(=O)NC(C)C)c1C(=O)O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
TAS1R3 Q7RTX0 1/20 0.40
TAS1R1 Q7RTX1 1/20 0.40
HPGD P15428 2/20 0.40
ALDH1A1 P00352 1/20 0.40
LMNA P02545 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
CNR2 P34972 1/20 0.38
PTPN1 P18031 1/20 0.38
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA7 P43166 1/20 0.37
CA9 Q16790 1/20 0.37
CA14 Q9ULX7 1/20 0.37
CXCR2 P25025 1/20 0.37
KDM4E B2RXH2 2/20 0.37
HTT P42858 1/20 0.37
HSD17B10 Q99714 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3377855 0.92 MEN1 (0.51) MEN1KMT2ATAS1R3TAS1R1HPGD
SCHEMBL3373245 0.90 KDM4E (0.39) MEN1KMT2ATAS1R3TAS1R1HPGD
SCHEMBL3377960 0.88 MEN1 (0.41) MEN1KMT2ATAS1R3TAS1R1HPGD
SCHEMBL551925 0.86 ALDH1A1 (0.42) MEN1KMT2ATAS1R3TAS1R1HPGD
SCHEMBL3374470 0.86 POLB (0.47) MEN1KMT2AHPGDALDH1A1CA2
SCHEMBL3377691 0.83 NPSR1 (0.42) MEN1KMT2ATAS1R3TAS1R1HPGD
SCHEMBL3378396 0.83 HCRTR1 (0.45) MEN1KMT2AHPGDALDH1A1L3MBTL1
SCHEMBL3379111 0.83 NPSR1 (0.40) HPGDALDH1A1LMNAL3MBTL1CA12
SCHEMBL3377828 0.82 MEN1 (0.51) MEN1KMT2ATAS1R3TAS1R1HPGD
SCHEMBL3377852 0.82 MEN1 (0.48) MEN1KMT2AHPGDALDH1A1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1517886-B1 NOVEL PHTHALAMIDE DERIVATIVES BAYER CROPSCIENCE AG (DE) 2010-11-10 EP disclosed
US-7132455-B2 Phthalamide derivatives BAYER CROPSCIENCE AG (DE) 2006-11-07 US disclosed
US-20060035967-A1 Novel phthalamide derivatives BAYER INTELLECTUAL PROPERTY GMBH (DE) 2006-02-16 US disclosed
EP-1517886-A1 NOVEL PHTHALAMIDE DERIVATIVES Bayer CropScience AG (DE) 2005-03-30 EP disclosed
WO-2004000796-A1 NOVEL PHTHALAMIDE DERIVATIVES BAYER CROPSCIENCE AG (DE) 2003-12-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060035967-A1 Novel phthalamide derivatives HDAC1, HDAC2, CRY1 MEN1 1772/4885KMT2A 102/4885TAS1R3 1783/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.